October 17, 2025

ESMO 2025: Dual targeted therapy shows promise in previously treated advanced kidney cancer patients – MD Anderson Cancer Center

October 17, 2025

Sevabertinib in Advanced HER2-Mutant Non–Small-Cell Lung Cancer

New England Journal of Medicine, Volume 393, Issue 18, Page 1819-1832, November 6, 2025.

October 16, 2025

Simple blood test shows promise in detecting amyotrophic lateral sclerosis early – Medical Xpress

October 16, 2025

Targeting CD19+ B Cells With Inebilizumab in Myasthenia Gravis – NeurologyLive

October 16, 2025

J&J heads to regulators with Tecvayli-Darzalex combo’s phase 3 win as earlier myeloma treatment – Fierce Pharma